Galmed Pharmaceuticals Stock Price History
| GLMD Stock | USD 2.90 0.03 1.02% |
Below is the normalized historical share price chart for Galmed Pharmaceuticals extending back to March 13, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Galmed Pharmaceuticals stands at 2.90, as last reported on the 17th of January 2025, with the highest price reaching 3.00 and the lowest price hitting 2.80 during the day.
If you're considering investing in Galmed Stock, it is important to understand the factors that can impact its price. Galmed Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.15, which attests that the entity had a -0.15% return per unit of risk over the last 3 months. Galmed Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Galmed Pharmaceuticals' Standard Deviation of 5.5, risk adjusted performance of (0.03), and Market Risk Adjusted Performance of (0.42) to validate the risk estimate we provide.
At present, Galmed Pharmaceuticals' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 252.4 K, whereas Common Stock Total Equity is forecasted to decline to about 41.4 K. . At present, Galmed Pharmaceuticals' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.08, whereas Price Earnings To Growth Ratio is forecasted to decline to (0). Galmed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of March 2014 | 200 Day MA 3.9977 | 50 Day MA 2.9878 | Beta 0.798 |
Galmed |
Sharpe Ratio = -0.1516
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GLMD |
Estimated Market Risk
| 4.41 actual daily | 39 61% of assets are more volatile |
Expected Return
| -0.67 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Galmed Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Galmed Pharmaceuticals by adding Galmed Pharmaceuticals to a well-diversified portfolio.
Galmed Pharmaceuticals Stock Price History Chart
There are several ways to analyze Galmed Stock price data. The simplest method is using a basic Galmed candlestick price chart, which shows Galmed Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 22, 2024 | 4.81 |
| Lowest Price | December 5, 2024 | 2.56 |
Galmed Pharmaceuticals January 17, 2025 Stock Price Synopsis
Various analyses of Galmed Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Galmed Stock. It can be used to describe the percentage change in the price of Galmed Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Galmed Stock.| Galmed Pharmaceuticals Price Action Indicator | (0.02) | |
| Galmed Pharmaceuticals Price Daily Balance Of Power | (0.15) | |
| Galmed Pharmaceuticals Accumulation Distribution | 1,254 | |
| Galmed Pharmaceuticals Price Rate Of Daily Change | 0.99 |
Galmed Pharmaceuticals January 17, 2025 Stock Price Analysis
Galmed Stock Price History Data
The price series of Galmed Pharmaceuticals for the period between Sat, Oct 19, 2024 and Fri, Jan 17, 2025 has a statistical range of 2.25 with a coefficient of variation of 14.58. Under current investment horizon, the daily prices are spread out with arithmetic mean of 3.2. The median price for the last 90 days is 3.03. The company completed 1:12 stock split on 30th of August 2024.| Open | High | Low | Close | Volume | ||
| 01/17/2025 | 2.93 | 3.00 | 2.80 | 2.90 | 18,810 | |
| 01/16/2025 | 2.79 | 2.98 | 2.79 | 2.93 | 19,606 | |
| 01/15/2025 | 3.01 | 3.01 | 2.79 | 2.79 | 19,426 | |
| 01/14/2025 | 2.94 | 2.98 | 2.82 | 2.82 | 9,319 | |
| 01/13/2025 | 2.93 | 3.01 | 2.84 | 2.88 | 27,913 | |
| 01/10/2025 | 2.94 | 3.07 | 2.84 | 2.90 | 16,331 | |
| 01/08/2025 | 2.91 | 3.04 | 2.85 | 2.94 | 26,516 | |
| 01/07/2025 | 3.08 | 3.10 | 2.99 | 2.99 | 45,922 | |
| 01/06/2025 | 3.54 | 3.58 | 2.97 | 3.02 | 104,151 | |
| 01/03/2025 | 3.36 | 3.61 | 3.36 | 3.43 | 38,841 | |
| 01/02/2025 | 3.20 | 3.60 | 3.20 | 3.32 | 56,110 | |
| 12/31/2024 | 3.17 | 3.19 | 3.04 | 3.19 | 33,577 | |
| 12/30/2024 | 3.02 | 3.12 | 3.01 | 3.12 | 46,310 | |
| 12/27/2024 | 3.11 | 3.15 | 3.00 | 3.12 | 53,647 | |
| 12/26/2024 | 3.19 | 3.19 | 3.06 | 3.12 | 47,415 | |
| 12/24/2024 | 3.03 | 3.10 | 3.00 | 3.04 | 10,995 | |
| 12/23/2024 | 3.05 | 3.14 | 2.91 | 3.03 | 15,747 | |
| 12/20/2024 | 3.28 | 3.32 | 2.89 | 3.05 | 72,141 | |
| 12/19/2024 | 2.90 | 3.35 | 2.81 | 3.07 | 136,103 | |
| 12/18/2024 | 3.04 | 3.11 | 2.90 | 2.90 | 38,519 | |
| 12/17/2024 | 3.25 | 3.39 | 3.01 | 3.01 | 50,311 | |
| 12/16/2024 | 3.11 | 3.39 | 3.00 | 3.27 | 92,132 | |
| 12/13/2024 | 2.77 | 2.97 | 2.73 | 2.97 | 31,667 | |
| 12/12/2024 | 2.77 | 2.92 | 2.77 | 2.82 | 9,567 | |
| 12/11/2024 | 3.05 | 3.05 | 2.88 | 2.88 | 17,807 | |
| 12/10/2024 | 2.93 | 3.07 | 2.91 | 3.05 | 35,842 | |
| 12/09/2024 | 2.80 | 2.96 | 2.80 | 2.90 | 15,240 | |
| 12/06/2024 | 2.71 | 2.80 | 2.56 | 2.80 | 52,756 | |
| 12/05/2024 | 2.76 | 2.86 | 2.56 | 2.56 | 91,308 | |
| 12/04/2024 | 2.96 | 2.96 | 2.76 | 2.76 | 38,975 | |
| 12/03/2024 | 2.97 | 3.02 | 2.83 | 2.87 | 20,331 | |
| 12/02/2024 | 2.83 | 3.10 | 2.75 | 2.94 | 69,126 | |
| 11/29/2024 | 2.78 | 2.94 | 2.78 | 2.86 | 18,415 | |
| 11/27/2024 | 2.90 | 2.91 | 2.71 | 2.86 | 53,993 | |
| 11/26/2024 | 2.93 | 2.93 | 2.74 | 2.87 | 37,084 | |
| 11/25/2024 | 2.75 | 2.92 | 2.68 | 2.87 | 50,504 | |
| 11/22/2024 | 2.81 | 2.82 | 2.75 | 2.75 | 16,696 | |
| 11/21/2024 | 2.94 | 2.94 | 2.75 | 2.80 | 45,426 | |
| 11/20/2024 | 3.05 | 3.05 | 2.85 | 2.96 | 49,537 | |
| 11/19/2024 | 2.86 | 3.01 | 2.85 | 3.00 | 40,135 | |
| 11/18/2024 | 2.96 | 2.98 | 2.84 | 2.94 | 24,002 | |
| 11/15/2024 | 3.03 | 3.12 | 2.88 | 2.93 | 35,545 | |
| 11/14/2024 | 3.00 | 3.13 | 3.00 | 3.10 | 17,588 | |
| 11/13/2024 | 3.08 | 3.08 | 2.93 | 2.99 | 35,714 | |
| 11/12/2024 | 2.99 | 3.18 | 2.86 | 3.02 | 63,175 | |
| 11/11/2024 | 2.89 | 2.96 | 2.73 | 2.88 | 78,346 | |
| 11/08/2024 | 3.10 | 3.11 | 2.81 | 2.97 | 138,900 | |
| 11/07/2024 | 3.03 | 3.23 | 2.97 | 3.08 | 89,940 | |
| 11/06/2024 | 3.27 | 3.45 | 3.04 | 3.10 | 102,038 | |
| 11/05/2024 | 3.24 | 3.38 | 3.24 | 3.37 | 24,241 | |
| 11/04/2024 | 3.19 | 3.57 | 3.15 | 3.24 | 66,505 | |
| 11/01/2024 | 3.34 | 3.38 | 3.10 | 3.24 | 67,596 | |
| 10/31/2024 | 3.51 | 3.55 | 3.04 | 3.34 | 149,141 | |
| 10/30/2024 | 3.56 | 3.90 | 3.43 | 3.50 | 82,535 | |
| 10/29/2024 | 3.87 | 3.94 | 3.57 | 3.66 | 147,052 | |
| 10/28/2024 | 3.97 | 4.16 | 3.90 | 3.90 | 37,989 | |
| 10/25/2024 | 4.00 | 4.14 | 3.93 | 3.93 | 25,829 | |
| 10/24/2024 | 4.37 | 4.68 | 4.00 | 4.03 | 61,929 | |
| 10/23/2024 | 4.79 | 4.79 | 4.18 | 4.54 | 121,669 | |
| 10/22/2024 | 4.68 | 4.81 | 4.37 | 4.81 | 134,333 | |
| 10/21/2024 | 3.90 | 4.70 | 3.80 | 4.68 | 375,660 |
About Galmed Pharmaceuticals Stock history
Galmed Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Galmed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Galmed Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Galmed Pharmaceuticals stock prices may prove useful in developing a viable investing in Galmed Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 207.7 K | 197.3 K | |
| Net Loss | -25.9 M | -24.6 M |
Galmed Pharmaceuticals Quarterly Net Working Capital |
|
Galmed Pharmaceuticals Stock Technical Analysis
Galmed Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Galmed Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Galmed Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Galmed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Galmed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.26) | |||
| Treynor Ratio | (0.43) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Galmed Stock analysis
When running Galmed Pharmaceuticals' price analysis, check to measure Galmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galmed Pharmaceuticals is operating at the current time. Most of Galmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Galmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Galmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world |